ESCLIM Drug Patent Profile

Name: ESCLIM Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Esclim patents expire, and when can generic versions of Esclim launch?

Esclim is a drug marketed by Women First Hlthcare and is included in one NDA.

The generic ingredient in ESCLIM is estradiol. There is one drug master file entry for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the estradiol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Esclim

A generic version of ESCLIM was approved as estradiol by BARR LABS INC on October 22^nd, 1997.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ESCLIM?
What are the global sales for ESCLIM?
What is Average Wholesale Price for ESCLIM?

Summary for ESCLIM

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	94
Patent Applications:	4,044
DailyMed Link:	ESCLIM at DailyMed

Drug patent expirations by year for ESCLIM

US Patents and Regulatory Information for ESCLIM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-001	Aug 4, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-004	Aug 4, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-002	Aug 4, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-003	Aug 4, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-005	Aug 4, 1998		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ESCLIM

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-004	Aug 4, 1998	4,842,864	⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-001	Aug 4, 1998	4,842,864	⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-005	Aug 4, 1998	4,842,864	⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-003	Aug 4, 1998	4,842,864	⤷ Start Trial
Women First Hlthcare	ESCLIM	estradiol	SYSTEM;TRANSDERMAL	020847-002	Aug 4, 1998	4,842,864	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ESCLIM

See the table below for patents covering ESCLIM around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	69724		⤷ Start Trial
Germany	3866408		⤷ Start Trial
European Patent Office	0288336	SELF-STICKING DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE AGENT	⤷ Start Trial
Spain	2027773		⤷ Start Trial
France	2612785		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for ESCLIM

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0136011	C00136011/03	Switzerland	⤷ Start Trial	PRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417
0136011	2000C/027	Belgium	⤷ Start Trial	PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0136011	99C0003	Belgium	⤷ Start Trial	PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306
0584952	99C0004	Belgium	⤷ Start Trial	PRODUCT NAME: ESTRADIOL, HEMIHYDRATE, NORETHISTERONE, ACETATE; NAT. REGISTRATION NO/DATE: NL 23753 19981210; FIRST REGISTRATION: SE - 14 007 19980306
0398460	SPC/GB04/032	United Kingdom	⤷ Start Trial	PRODUCT NAME: ESTRADIOL, OPTIONALLY IN THE FORM OF A HYDRATE, TOGETHER WITH DROSPIRENONE; REGISTERED: NL RVG 27505 20021211; UK PL 00053/0341 20040310
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Deep Research

Questions you can ask:

Summary for ESCLIM

Make Better Decisions: Try a trial or see plans & pricing